Laboratory Pattern Indicates Age-Related Primary Testicular Insufficiency (Compensated Hypogonadism)
This 77-year-old man has compensated primary testicular insufficiency—his testosterone level of 19.1 nmol/L (approximately 550 ng/dL) is within the normal range, but his elevated FSH (25.1 IU/L) and elevated LH (9.6 IU/L) reveal that his testes are failing and his pituitary is working overtime to maintain borderline-adequate testosterone production. 1
What This Pattern Means
This hormonal profile represents primary (hypergonadotropic) hypogonadism in a compensated state—a common finding in aging men where:
- Elevated FSH (25.1 IU/L): Markedly elevated, approximately 2-3 times the upper limit for his age (normal at 70 years: 2.71-14.2 IU/L), indicating primary testicular failure 2
- Elevated LH (9.6 IU/L): Mildly elevated, near the upper limit for age 70 (normal: 2.22-11.2 IU/L), confirming the pituitary is compensating for testicular dysfunction 2
- Normal testosterone (19.1 nmol/L): Falls within the reference range for his age (8.6-30.7 nmol/L at 70 years), but only maintained through increased gonadotropin drive 2
- Normal prolactin (5.7 ng/mL): Rules out hyperprolactinemia as a cause of secondary hypogonadism 3
The Aging Male Phenomenon
This pattern is characteristic of the aging process in men, where primary testicular insufficiency develops gradually 4. Research demonstrates that healthy elderly men show:
- Impaired Leydig cell function requiring increased LH stimulation to maintain testosterone 4
- A 2-3 fold increase in gonadotropins despite only modest testosterone decline 4
- Coexistent hypothalamic-pituitary dysfunction that blunts the expected gonadotropin response 5
The key insight: His gonadotropins are elevated because his testes are failing, but they're not elevated enough given the degree of testicular dysfunction—revealing an additional age-related impairment in hypothalamic-pituitary function 5, 6.
Clinical Significance
Does He Have Hypogonadism?
No, by strict biochemical criteria he does not have hypogonadism because his total testosterone is normal 1, 3. However, this requires important caveats:
Check free or bioavailable testosterone: If SHBG is elevated (common with aging), his free testosterone may be low despite normal total testosterone 1, 7. Recent evidence strongly supports that free testosterone, not total testosterone, determines biological activity and feedback regulation 7.
Assess for symptoms: The 2025 EAU guidelines emphasize that hypogonadism requires both biochemical evidence AND symptoms 1. Key symptoms include:
- Sexual: reduced libido, erectile dysfunction, decreased morning erections
- Physical: decreased energy, reduced physical strength, hot flushes
- Psychological: low mood, fatigue, decreased motivation 1
This is a transitional state: His elevated gonadotropins predict future testosterone decline as testicular reserve continues to diminish with age.
Recommended Next Steps
Measure free testosterone or calculate bioavailable testosterone using SHBG and albumin—this is critical given his age 1, 2, 7
Perform symptom assessment using validated questionnaires for late-onset hypogonadism symptoms 1
Evaluate for underlying causes of accelerated testicular aging:
- Chronic systemic diseases (diabetes, metabolic syndrome)
- Medications affecting gonadal function
- History of cryptorchidism, testicular trauma, or infections 1
Do NOT initiate testosterone therapy based solely on elevated gonadotropins with normal total testosterone 3. Testosterone therapy is only indicated if he has both symptoms AND consistently low testosterone (or low free testosterone) 1, 3.
Common Pitfall to Avoid
Do not interpret the normal testosterone as reassuring without checking free testosterone. In men with elevated SHBG (which increases with aging), total testosterone can be misleadingly normal while free testosterone is low—and it's the free testosterone that matters biologically 1, 7. The elevated gonadotropins are telling you his testes are struggling; you need to determine if they're struggling enough to cause true androgen deficiency at the tissue level.